Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3636 Texture analysis in the prediction of progression-free survival (PFS) in patients with progressive neuroendocrine tumors (NETs) treated with lanreotide autogel (LAN) in the prospective, open-label, non-comparative, phase 2 CLARINET FORTE trial

Introduction: Tumor texture analysis may provide new imaging biomarkers for PFS prediction in patients with NETs.

Conference:

Presenting Author:

Authors: Dromain C, Truong Thanh X, Grandoulier A, Pavel M,

Keywords: texture analysis, progression-free survival, neuroendocrine tumor,

#3212 CLARINET FORTE: Characterization of Pharmacokinetics (PK), efficacy and safety in patients with progressive neuroendocrine tumors (NETs) treated with Lanreotide Autogel (LAN) 120 mg every 14 days (q14d)

Introduction: CLARINET FORTE investigated efficacy and safety of LAN 120 mg q14d (frequent dose) in patients with pancreatic (panNET) or midgut NETs after progression while on LAN 120 mg every 28 days (q28d; standard dose) (NCT02651987).

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Dehez M, Brendel K, Sarr C, Björnsson M, Truong Thanh X,

Keywords: NET, PK, PFS, tumor size, safety, somatostatin analogues, high dose,

#2932 Evaluation of Nurse Preferences between the Lanreotide Autogel New Syringe and Octreotide Long-Acting Release Syringe: An International Simulated Use Study (PRESTO)

Introduction: A new lanreotide autogel/depot (LAN) syringe was developed based on feedback from a human factors study to improve user experience.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Truong Thanh X, Adelman D, Feuilly M, Houchard A, Cella D,

Keywords: Somatuline lanreotide, syringe, neuroendocrine tumors, medical treatment,

#1808 Lanreotide Autogel/Depot (LAN) in Combination with Peptide Receptor Radionuclide Therapy (PRRT) in Progressive Digestive and Lung Neuroendocrine Tumours (NETs): Design of the PRELUDE Study

Introduction: PRRT has potential to control progressive NETs and has been used in combination with somatostatin analogues such as LAN.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Prasad V, Truong Thanh X, Houchard A, Bodei L,

Keywords: PRRT, lanreotide,